FDA approves first-of-a-kind seasonal flu vaccine
November 22, 2012 (WASHINGTON) -- The Food and Drug Administration says it has approved the first seasonal flu vaccine made using animal cell technology, rather than the half-century egg method.
The FDA approved Novartis' Flucelvax to prevent influenza in people 18 years and older.
The new method has been promoted by U.S. health officials because it is faster than egg-based production and could speed up manufacturing in the event of a pandemic.
In the older method, virus samples are injected into specialized chicken eggs and incubated. The egg fluids are later harvested, concentrated and purified into the vaccine.
With cell technology, small amounts of virus are put in fermenting tanks with nutrients and cells derived from mammals. The virus is then inactivated, purified and put into vaccine vials.
- Grand Blue Line stop closed by water main break 29 min ago
- Spring-like day followed by snow
- H.S. wrestling coach accused of sex with student
- ABC7 First Alert Weather Forecast
- Malaysia Airlines plane, Flight MH370, still missing
- Chicago pothole 'strike teams,' formed by CDOT crews
- Firefight causes flooding in Irving Park homes
- Sarah Kustok defends father at murder trial
- Gay marriage at center of 81st District GOP race
- Alvarez, Kirk call to end online sex trafficking
- Officer hit in face by bullet fragment released
- Man struck by cars in Lincolnwood dies, police say
- Semi crash spills plastic beads, slows Tri-State
- abcnews: Happy Couples Share 6 Common Habits
- Some IL concealed carry applicants notified...
5 min ago